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Abstract:1
The purpose of this study was to determine the effects of smoke induced acute lung2
injury (S-ALI), extracorporeal membrane oxygenation (ECMO) and transfusion on3
oxidative stress and plasma selenium levels. Forty ewes were divided into (i) healthy4
control (n=4), (ii) S-ALI control (n=7), (iii) ECMO control (n=7) (iv) S-ALI + ECMO5
(n=8) and (v) S-ALI + ECMO + packed red blood cell (PRBC) transfusion (n=14).6
Plasma thiobarbituric acid reactive substances (TBARS), selenium and glutathione7
peroxidase (GPx) activity were analysed at baseline, after smoke injury (or sham) and8
0.25, 1, 2, 6, 7, 12 and 24 hours after initiation of ECMO. Peak TBARS levels were9
similar across all groups. Plasma selenium decreased by 54% in S-ALI sheep10
(1.36±0.20 to 0.63±0.27 µmol/L, p < 0.0001), and 72% in sheep with S-ALI + ECMO11
at 24hr (1.36±0.20 to 0.38±0.19, p < 0.0001). PRBC transfusion had no effect on12
TBARS, selenium levels or glutathione peroxidase activity in plasma. While ECMO13
independently increased TBARS in healthy sheep to levels which were similar to the14
S-ALI control, the addition of ECMO after S-ALI caused a negligible increase in15
TBARS. This suggests that the initial lung injury was the predominant feature in the16
TBARS response. In contrast, the addition of ECMO in S-ALI sheep exacerbated17
reductions in plasma selenium beyond that of S-ALI or ECMO alone. Clinical studies18
are needed to confirm the extent and duration of selenium loss associated with19
ECMO.20
21
Key words: Extracorporeal membrane oxygenation, acute lung injury, selenium,22
oxidative stress, antioxidants.23
24
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ACT, Activated clotting time; ALT, Alanine transaminase; ARDS, Acute respiratory1
distress syndrome; CoHb, Carboxyhemoglobin; ECMO, Extracorporeal membrane2
oxygenation; GPx, Glutathione peroxidase; ICE, Intracardiac echocardiography; ICU,3
Intensive care unit; MDA, Malondialdehyde; MOF, Multi-organ failure; MV,4
Mechanical ventilation; PRBC, Packed red blood cell; ROS, Reactive oxygen species;5
TBARS, Thiobarbituric acid reactive substances.6
7
8
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Introduction1
Patients with acute respiratory distress syndrome (ARDS) are critically ill and exhibit2
increased oxidative stress and reduced selenium levels compared to other hospital in-3
patients [1, 2]. Regardless of the cause of lung injury, oxidative stress is thought to be4
a major contributor to the pathogenesis and progression of ARDS [1, 3]. The mortality5
among patients with acute lung injury (ALI) and ARDS may be as high as 41% and in6
severe cases of ARDS, veno-venous extracorporeal membrane oxygenation (VV7
ECMO) provides a rescue therapy for temporary respiratory support [4, 5].8
9
VV ECMO involves the insertion of large cannulas into the central venous circulation,10
redirecting the blood through an oxygenator (artificial lung), where carbon dioxide is11
removed and oxygen is added. (Fig. 1) Oxygenated blood is then returned through a12
cannula to the right side of the heart before passing through the lungs. ECMO circuits13
have a large surface area to enable efficient gaseous exchange, however exposure of14
the patient’s blood to these foreign surfaces initiates an inflammatory response [6] as15
well as absorbing trace elements and drugs [7, 8].16
17
[insert Figure 1]18
19
Oxidative stress occurs when excessive production of reactive species of oxygen20
(ROS) overwhelms the antioxidant system [9]. Excessive ROS production during21
sepsis, systemic inflammation and/or ischemia-reperfusion injury has been associated22
with cellular, tissue and ultimately organ injury [9]. Additionally, extracorporeal23
circuits (ECMO, dialysis, cardiac bypass) involve extensive blood contact with a24
foreign surface and this coupled with hyperoxia and massive blood transfusions have25
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the potential to augment oxidative stress [10, 11]. Whether oxidative stress in this1
setting contributes to the morbidity/mortality risk of patients on ECMO is unclear.2
3
Selenium is a trace element incorporated into a variety of selenoproteins involved in4
antioxidant, thyroid, immunity and inflammatory regulation [12]. While some studies5
have demonstrated a negative correlation between selenium and oxidative stress [13,6
14], reduced plasma selenium levels have also been independently associated with7
worse outcomes in some critically ill patients [15]. Glutathione peroxidase (GPx) a8
primary antioxidant enzyme, requires selenium for normal functioning [16]. The9
reduction of serum selenium levels during critical illness and inflammatory10
syndromes [17] may compromise GPx activity. Despite its importance to antioxidant11
function (as well as thyroid and immune function), the impact of ECMO on selenium12
levels has not been previously investigated. We hypothesised that the addition of an13
ECMO circuit to a critically ill host would result in selenium reductions and14
exacerbate oxidative stress levels. We sought to investigate the impact of acute lung15
injury, (i.e. critical injury), ECMO and transfusion, individually and in combination16
on oxidant status and plasma selenium levels using an ovine model of smoke induced17
acute lung injury (S-ALI).18
19
Materials and Methods20
The animal ethics committees of The University Of Queensland (QUT/194/12) and21
The Queensland University of Technology (1100000053) approved this study that22
adhered to the National Health and Medical Research Council (NHMRC) Code of23
Practice for the Care and Use of Animals for Scientific Purposes [18]. Forty24
Australian Samm Border Leicester Cross ewes (1-3 yr old) were divided into the25
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following groups: (i) healthy control (n=4), (ii) ECMO control (healthy sheep +1
ECMO, n=7), (iii) S-ALI control (n=7), (iv) S-ALI + ECMO (n=8) and (v) S-ALI +2
ECMO + PRBC transfusion (n=14). Half the transfused group received fresh PRBC3
(< 5 days old) and the other half received aged PRBC (>35 days old).4
5
Animal Preparation:6
Sheep were allocated to five different groups. Each sheep was anaesthetised and7
instrumented as previously detailed [19]. Briefly, standard monitoring was utilised,8
including- arterial blood pressure; three-lead electrocardiograph (ECG); oxygen9
saturation monitoring; continuous hemodynamic monitoring; regular blood gas10
analysis (ABL825 blood gas analyser, Radiometer, Copenhagen, Denmark); and11
continuous cardiac output and SvO2 monitoring (Swan-Ganz CCOmbo, Edwards12
Lifesciences, California, USA). Sheep were ventilated through a 10Fr tracheostomy13
tube. Normothermia (39ºC) was maintained with a warming blanket.14
15
Experimental Protocol16
Acute lung injury was delivered as previously described [20]. Cooled cotton smoke17
was administered through a custom designed hand ventilator. Animals received a total18
of 14 breaths of cotton smoke (or sham for controls) to achieve a carboxyHb (COHb)19
level of 35-45%. A two hour lung injury development period was allowed to prior to20
initiating ECMO.21
22
ECMO Circuits23
The ECMO circuits comprised a Quadrox PLS oxygenator, Bioline tubing and24
Rotaflow pump head (Maquet Cardiopulmonary AG, Hechinger Strabe Germany).25
Page 9 of 28
Ac
ce
pte
d M
an
us
cri
pt
9
Circuits were primed with Plasmalyte P-148 (Baxter Healthcare Pty Ltd. Toongabbie,1
NSW, Australia), 4% human albumin (CSL Behring. Broadmeadows, Vic, Australia),2
1000IU porcine heparin (Pfizer Australia Pty Ltd. West Ryde, NSW, Australia) and3
warmed to 38ºC. Target ECMO flows were calculated at two thirds of the pre-ECMO4
cardiac output. Sodium chloride (0.9%) (Baxter Healthcare Pty Ltd. Toongabbie,5
NSW, Australia) were administered intravenously as needed to maintain these target6
flows. FiO2 was set at 100% and ECMO gas flows set to a ratio 0.8:1 of blood flow.7
Anticoagulation was achieved with 3000IU of heparin given to the sheep prior to8
ECMO cannulation and the activated clotting time (ACT) was targeted between 200-9
300sec. Cannulas were a 19 Fr (return cannula) and a 21Fr (access cannula)10
Carmeda bonded femoral venous cannula (Medtronic Pty Ltd, Minneapolis, MN)11
positioned via the right external jugular. Final cannula position was confirmed using a12
technique of intra-cannula echo using an intra-cardiac echocardiography probe [21].13
14
Bilateral 20Fr intercostal catheters were inserted two hours after commencement of15
ECMO to collect pleural effusion fluid. After 24 hours sheep were euthanized using16
sodium pentobarbitone (100mg/kg).17
18
Ovine PRBC preparation19
Sheep in the transfusion arm received two units of leukofiltered cross-match20
compatible ovine PRBC that was (i) less than 5 days (fresh) or (ii) 35-42 days (aged)21
using a previously described protocol [22]. Transfusion of the PRBC commenced22
after the 6 hr samples had been collected.23
24
Blood Sample Collection25
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Arterial blood samples were collected at anaesthetic induction (baseline), after smoke1
injury (PS), 15 minutes after ECMO start (0.25 hr) then at 1, 2, 6, 7, 12, and 24 hours.2
Blood for selenium analysis was collected into trace free element tubes (Greiner Bio-3
One, Monroe, North Carolina, United States), and the separated plasma was stored at4
4C until analysis. EDTA blood samples were immediately centrifuged 3000g x5
10min @ 4C and plasma stored at -80C until analysis of thiobarbituric acid reactive6
substances (TBARS) and GPx.7
8
Measurement of Selenium, GPx and TBARS9
Plasma selenium levels were analysed by graphite furnace atomic absorption10
spectrometry with Zeeman background correction (GF AAS) using a Varian AA280Z11
analyzer (Agilent Technologies Inc, Santa Clara CA, United States) as previously12
described.[23] Inter-assay imprecision was 5.5%. Plasma TBARS and GPx were13
analysed using commercially available assay kits (Cayman Chemical Company, Ann14
Arbor, MI).15
Baseline data depicted in figure 3 (A, B and C) include baseline data from all groups16
(i.e. n=40)17
18
Statistical Analysis19
Summary data are displayed as mean ± standard deviation with associated 95% C.I.20
(difference of the mean) unless otherwise stated. A two-way ANOVA with21
unmatched pairs and a Tukey post hoc correction was used to compare means within22
and between groups (Graphpad Prism 6.0a). Statistical significance was assumed23
when p < 0.05. A linear regression was performed to determine the relationship24
between selenium and GPx or selenium and TBARS (Graphpad Prism 6.0a).25
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1
Results2
The sheep in this study weighed an average of 48.6 ± 6.0 kg. Table 1 summarizes3
PaO2, and COHb levels, heart rate, mean arterial pressure (MAP), inotrope use4
(noradrenaline, dopamine and vasopressin) and fluid requirements across the various5
study groups. COHb levels ranged from 25.3-53.6% after smoke injury while PaO26
levels progressively declined in the S-ALI control sheep over the 24 hours period.7
(Table 1). Heart rate was similar across all the groups, however the average MAP8
over the study period was lower in the S-ALI control, S-ALI + ECMO and S-ALI +9
ECMO + Tf sheep compared to healthy control and ECMO controls. Inotropes10
(noradrenaline and dopamine) were required in the S-ALI control, S-ALI + ECMO11
and S-ALI + ECMO + Tf sheep to maintain cardiac function and blood pressure, but12
not in the healthy control or ECMO control sheep. Vasopressin was required in 5/8 of13
the S-ALI + ECMO and 4/14 of the S-ALI + ECMO + Tf sheep as they were mildly14
vasoplegic and non-responsive to noradrenaline. (Table 1). Saline was administered15
intravenously as required to maintain ECMO flows at two thirds cardiac output. As a16
result sheep in the S-ALI control, S-ALI + ECMO and S-ALI + ECMO + Tf groups17
received significantly more fluids and thus had  a positive fluid balance at 24hr.18
Despite a higher positive fluid balance sheep in these groups, there was no significant19
difference in Hb compared to the ECMO control sheep. (Figure 2).20
21
Serial changes to relevant biochemical parameters are detailed in Figure 2. The pH22
levels remained consistent throughout the study (Figure 2B). Albumin levels were23
reduced significantly (p < 0.05) in the S-ALI control and S-ALI + ECMO groups after24
6 hours Figure 2C). Bilirubin levels rose significantly in the healthy control and25
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ECMO control sheep (p < 0.05) after 12 and 18 hours respectively but remained1
unchanged in the S-ALI control and S-ALI + ECMO groups (Figure 2F). Samples in2
S-ALI + ECMO +Tf group were unavailable for albumin, creatinine, ALT and3
bilirubin analysis.4
5
As no significant differences were detected between fresh and aged PRBC transfused6
sheep for plasma TBARS, selenium and GPx, the data was combined into a single7
transfusion group (n=14) and henceforth labelled S-ALI + ECMO + Tf.8
9
[insert table 1]10
[insert figure 2]11
12
13
Plasma Thiobarbituric Acid Reactive Substances (TBARS)14
Plasma TBARS levels remained unchanged in the healthy control sheep (Figure 3A).15
Compared to healthy control sheep, plasma TBARS were significantly higher at16
corresponding time points between 0.25h and 24h for all groups (p < 0.001). Plasma17
TBARS were significantly elevated in S-ALI control sheep, peaking at 2h (1.32±0.4018
to 2.90±0.35 µM, 95% CI -2.78 to -1.16; p < 0.001). Plasma TBARS rose rapidly with19
the initiation of ECMO in ECMO control sheep, peaking at 6h (1.32±0.40 to20
3.11±0.70 µM, 95% CI -2.60 to -0.98; p < 0.0001). In S-ALI + ECMO sheep plasma21
TBARS were 155% above baseline (1.32±0.40 vs 3.37±0.35 µM, 95% CI -2.82 to -22
1.29; p < 0.0001) and 200% above baseline in S-ALI + ECMO + Tf sheep at 24h,23
(1.32±0.40 vs 3.97±0.44 µM, 95% CI -3.27 to -2.04; p < 0.0001), but this was not24
significantly higher than S-ALI control or ECMO control. No differences were25
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detected due to PRBC transfusion between 7h and 24h in the S-ALI + ECMO + Tf1
group.2
3
[insert figure 3]4
5
Plasma Selenium levels6
Baseline plasma selenium levels were similar amongst all sheep. In ECMO control7
sheep, plasma selenium levels declined at 2h to 46% (1.36±0.20 to 0.73±0.21 µmol/L.8
95% CI 0.29 to 0.97; p < 0.0001), they rose after 6h but were still below baseline at9
24h (0.96±0.17 µmol/L. 95% CI 0.06 to 0.74; p < 0.01). In S-ALI control sheep10
plasma selenium began to decline at 6h and were significantly below baseline levels at11
24h (54% reduction; 1.36±0.20 to 0.63±0.27 µmol/L at 24h. 95% CI, 0.39 to 1.07; p <12
0.0001) (Figure 3B). The double insult of S-ALI followed by ECMO produced the13
greatest decline in plasma selenium of 72% at 24h (1.36±0.20 to 0.38±0.19, 95% CI14
0.66 to 1.3; p < 0.0001). Between group comparisons of plasma selenium results15
detected a significant difference between S-ALI + ECMO vs ECMO control at 24h16
(0.38±0.19 vs 0.96±0.17 µmol/L, 95% CI 0.15 to 1.01; p < 0.001). PRBC transfusions17
did not cause any change.18
19
Pleural effusion fluid collected from S-ALI+ ECMO sheep had selenium levels of20
0.5±0.1 µmol/L (n=16). Linear regression revealed that decreased plasma selenium21
was associated with increased plasma TBARS for S-ALI + ECMO sheep (r2 = 0.50, p22
< 0.0001). This association was reduced when data from all sheep on ECMO was23
combined (healthy and S-ALI; r2 = 0.39, p < 0.001).24
25
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Plasma Glutathione Peroxidase activity1
No changes in plasma GPx activity occurred in healthy control sheep (Figure 3C).2
Though not statistically significant, the following trends were observed: (i) Smoke3
injury (S-ALI control) induced a rapid but transient increase in plasma GPx,4
(1.93±0.55 to 2.67±0.32 nmol/min/ml), returning to baseline levels at 24h (1.94±0.415
nmol/min/ml). (ii) ECMO-control experienced a similar increase in plasma GPx6
(1.93±0.55 to 2.63±0.47 nmol/min/ml) after ECMO initiation, trending back to7
baseline levels at 24h. (iii) S-ALI + ECMO produced peak plasma GPx responses8
similar to ECMO control (2.86±0.6 nmol/min/ml), which then declined 1h after9
ECMO began, being below baseline at 24h (1.43±0.24 vs 1.93±0.55 nmol/min/ml).10
(iv) plasma GPx activity was elevated after smoke injury and during the initial stages11
of ECMO in ECMO + S-ALI + Tf group. No effect of PRBC transfusion was12
detected.13
14
15
16
Discussion17
This ovine model has generated two significant findings. First, we found that both S-18
ALI and ECMO independently increased oxidative stress, but when conducted19
sequentially (i.e. S-ALI followed by ECMO) the latter caused no additional impact on20
oxidative stress. Secondly, S-ALI caused significant reductions in plasma selenium21
and subsequent ECMO support exacerbated this loss.22
23
ARDS is associated with a dramatic and uncontrolled increase in ROS production that24
contributes to morbidity and mortality [3, 24]. When conventional medicine fails in25
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these patients, ECMO is one of the few remaining life-saving options [4]. Previous1
ECMO studies in pediatrics, [25] rabbits, [26] lambs [27] sheep [28] and pigs [29]2
have shown significant elevations in lipid peroxides. However it is difficult to3
translate these findings to critically ill adult patients as (i) pediatric patients have4
significantly different bodyweight to ECMO surface area ratios and (ii) (with the5
exception of the sheep study [28]) in all the other animal models ECMO was initiated6
in a healthy host. Thus the impact of acute illness on overall oxidative stress could not7
be determined.8
9
We demonstrated that both S-ALI and ECMO independently increased lipid10
peroxidation in plasma. Over the 24h study period, we found that while ECMO use in11
sheep with S-ALI resulted in an increase in lipid peroxides, the levels were not12
significantly greater than for S-ALI or ECMO alone. Our results contradict the13
findings of an earlier similar study, [28] which measured lipid peroxides in a model of14
S-ALI and veno-arterial ECMO, and demonstrated significant increases in lipid15
peroxides after ECMO was initiated in a S-ALI animal. As that study was conducted16
20 years ago their ECMO circuit was significantly different, which may account for17
the disparity in results to our study. Their circuit included a silicon membrane18
oxygenator with a large surface area (4.5 m2), a servo controlled roller pump and19
venous blood drainage reservoir in a venous arterial ECMO configuration. In20
comparison, our study utilised a low volume closed circuit, polymethylpentene fibre21
oxygenator, (surface area 1.8 m2), with centrifugal pump and coated tubing in a VV22
ECMO configuration. We speculate that the improvements in ECMO technology and23
circuit biocompatibility have reduced the trauma associated with continual blood24
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exposure to the foreign circuit and consequently dampened any increase in lipid1
peroxidation.2
3
Independent of oxidative stress, reductions in serum or plasma selenium during sepsis4
and ARDS are associated with multi-organ failure, inflammatory syndromes,5
increased infections and increased mortality [3, 15, 24, 30, 31]. Some studies have6
shown that selenium replacement in critically ill patients is beneficial in reducing7
infections (such as ventilator acquired pneumonia) and mortality [32, 33]. This led us8
to investigate the impact of ECMO on plasma selenium levels. We demonstrated that9
S-ALI and ECMO independently led to significant reductions in plasma selenium (5410
and 46% respectively). Notably the “two-hit” combination of S-ALI + ECMO11
resulted in a greater loss (72%). We postulate that the observed plasma selenium12
reductions may be attributed to an acute phase response, circuit absorption and13
hemodilution (due to the ECMO priming solution and ongoing fluid replacement).14
The acute phase response seen during inflammatory syndromes increases the15
permeability of cellular membranes to proteins and micronutrients, that are16
redistributed to tissues [34]. Hypoalbuminaemia, ascites, high volume requirement17
and significant pleural effusions confirm this response in the sheep of this current18
study. Measurement of the selenium concentration in the pleural effusion fluid also19
confirms this fluid to be one avenue of significant selenium loss. This may have some20
clinical relevance as pleural effusions are not uncommon in VV ECMO patients.21
22
We have previously demonstrated that cardiopulmonary bypass circuits absorb trace23
elements [7]. Given the similarities between cardiopulmonary bypass and ECMO24
circuits this presents another mechanism for the loss of trace elements such as25
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selenium. In addition because patients on ECMO are critically ill, the associated1
altered gut motility and absorption may compromise dietary intake of trace elements2
[35]. Since ECMO support often lasts for over a week, the combination of acute phase3
redistribution, decreased dietary intake and loss through circuits absorption could lead4
to a true selenium deficiency .5
6
While many studies cite plasma or serum selenium reductions in the critically ill as an7
independent predictor of poor outcome, it is important to recognise that plasma8
selenium levels provide limited information regarding functional selenium status.9
Selenium in plasma exists in several forms, 40-70% is in the functional form10
selenoprotein P, GPx-3 accounts for another 20-40% and 6-10% is bound to albumin11
[36]. Unfortunately in this present study we did not have the capacity to measure12
selenoprotein P. Plasma GPx (GPx-3) is an important extracellular antioxidant and13
can be used at times as a surrogate marker of selenium status. GPx is produced14
primarily in the kidneys and secondarily in the liver [37] and while the association15
between selenium and GPx activity is well established, how rapidly GPx synthesis in16
the kidneys and liver is altered by acute reductions in selenium is largely unknown.17
We attempted to measure kidney (creatinine) and liver function (bilirubin and ALT).18
Creatinine levels remained stable in all groups, however there were increased19
bilirubin levels in the healthy control and ECMO control sheep but theses were stable20
in the S-ALI control and S-ALI + ECMO sheep (Figure 2 E). In contrast ALT levels21
were similar across the study groups (Figure 2 F). The inconsistency between22
bilirubin and ALT levels suggests that the high positive fluid balance in the S-ALI23
control and S-ALI + ECMO sheep has possibly diluted both bilirubin and ALT levels.24
For GPx activity our data suggests a trend towards GPx reductions after 6 hours in S-25
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ALI + ECMO sheep, which we may be indicative of a delayed response to the1
reductions in plasma selenium.2
3
ECMO patients often required multiple transfusions [38, 39], which may convey an4
increased risk of transfusion related complications. Previous studies in neonates and5
animals have demonstrated increases in lipid peroxidation after PRBC transfusions6
[40-43]. We and others have shown that PRBC contain low selenium levels [44] and7
reduced antioxidant capacity [45]. Despite these observations, in this model PRBC8
transfusions had no significant impact on oxidative stress, selenium or GPx. One9
reason for the lack of response may be because of the small volume of PRBC10
transfused and the period of observation too short. In addition, the magnitude of the S-11
ALI induced oxidative stress and selenium alterations could have masked any12
transfusion related effect. Thus the effect of massive PRBC transfusion during a13
prolonged ECMO course remains to be investigated.14
15
Investigations into the in vivo impact of ECMO using modern adult ECMO cannulas16
and circuits can only be performed with a large animal model. Sheep models have the17
advantage of weight ranges, pulmonary and cardiac physiology, coagulation and18
inflammatory systems which are similar to humans [19]. However, large animal19
models are expensive and this restricted the sample size of each group in our study.20
The incremental design of this in vivo study enabled the differentiation of the effect of21
ECMO from that of other variables such as S-ALI and transfusion but had several22
limitations. The complexity of maintaining a critically ill animal restricted the23
duration of the experiment to 24 hours, thus preventing the study of longer-term24
effects on oxidative stress. While this study utilised a common measure of lipid25
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peroxidation (TBARS), it may have benefited from analysing F2-isoprostanes or1
protein carbonyl measurements. The analysis of tissue samples from specific organs2
may have also revealed localized decreases in selenium as well as consequences of3
oxidative stress that were not apparent using systemic blood samples, however in an4
ECMO model where sheep are anticoagulated, serial tissue samples are not practical5
due to the risk of catastrophic bleeding.6
7
During VV ECMO, blood flow is a key determinant of oxygenation as significant8
shunting can occur in injured lungs, and suboptimal ECMO flows may result in9
systemic hypoxia. Clinically, patients with a high cardiac output who are dependent10
on higher ECMO flows for oxygenation require a degree of fluid resuscitation.11
Alternatives to optimise oxygenation and minimize fluid resuscitation in these12
patients include pharmacological interventions to reduce cardiac output, deep13
sedation, paralysis or induced hypothermia. To avoid additional confounders in this14
study we chose to maintain ECMO flows to 2/3 of cardiac output across all sheep and15
to only use fluids and vasoactive agents to achieve this. Despite the high dose16
vasopressor and inotrope drugs in the S-ALI sheep (Table 1) the excessive capillary17
leak necessitated significant fluid resuscitation to maintain target ECMO blood flows.18
Notwithstanding this effort, we acknowledge that the resulting higher fluid balance in19
S-ALI + ECMO ± Tf sheep (Table 1) may have contributed to lower selenium levels20
and a blunted TBARS response.21
22
Conclusions23
We have demonstrated that 24 hours of ECMO induced increased plasma TBARS in a24
healthy host. However in a S-ALI animal, ECMO did not cause any additional25
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TBARS increase. Nevertheless the combination of S-ALI and ECMO lead to1
profound reductions in plasma selenium. It is unclear if this represents a true2
deficiency or is a result of fluid shifts associated with the acute phase response. In3
addition to influencing antioxidant function, reductions in plasma selenium may also4
compromise the function of thyroid and immune function. Clinical studies are now5
needed to confirm if these effects on selenium, and oxidative stress are augmented or6
diminished with longer periods of ECMO support, and to assess if normalisation of7
selenium through supplementation is beneficial.8
9
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Header: Table 1. Comparison of basic physiological variables.1
Footer: COHb- carboxyhemoglobin; Tf- transfusion; MAP- mean arterial pressure.2
COHb values are after smoke breath cycles completed. Heart rate, MAP and Inotrope3
values are mean±S.D. for the period between smoke injury/SHAM (2 hrs prior to4
ECMO) and 24 hrs ECMO. Asterisk denotes comparison between S-ALI control and5
S-ALI+ECMO / S-ALI+ECMO+transfusion (p < 0.05).6
7
Figure 1. Schematic diagram of sheep on VV ECMO. ECMO cannulas are inserted8
via right internal jugular vein (RIJV). Reproduced with permission [19]9
10
Figure 2. Effect of ECMO and/or S-ALI on parameters of Hemoglobin (A), pH11
(B), Albumin (C), Creatinine (D), Alanine Transaminase (E) and Bilirubin (F). B,12
baseline; PS, post-smoke injury, numbers represent hours of ECMO support. a and b13
(Fig C.) indicate significant difference (p < 0.05) with respect to healthy control and14
ECMO control. Asterisks indicate significant difference (p < 0.05) with respect to15
baseline.16
17
18
Figure 3. Effects of smoke injury (S-ALI) ± ECMO ± transfusion (Tf) on (A)19
plasma thiobarbituric acid reactive substance (TBARS), (B) selenium and (C)20
glutathione peroxidase (GPx) levels.
 The mean baseline data is represented by a full21
horizontal line. Dashed horizontal line is ± 1SD. PS-2h post smoke/sham injury.22
Numbers represent hours after initiation of ECMO support. Data are mean±SD.23
Asterisks indicate significant within group difference compared to baseline levels.24
25
26
Page 25 of 28
Ac
ce
pte
d M
an
us
cri
pt
25
Table.11
Healthy Control
(n=4)
ECMO control
(n=7)
S-ALI Control
(n=7)
S-ALI + ECMO
(n=8)
S-ALI + ECMO
+ Tf
(n=14)
PaO2 (mmHg)
Pre-ECMO
24 hr
533±39
526±23
395±162
148±40
562±27
169±148
409±120
161±48
403±172
139±24
COHb (%)
[range]
4.0±0.4
[3.6 – 4.3]
4.2±0.6
[3.5 – 4.7]
43.3±8.8
[30.5 – 53.6]
44.2±5.6
[35.0 – 51.4]
39.35±6.40
[25.3 – 48.4]
Heart Rate 108±16 102±17 114±17 103±17 100±15
MAP (mmHg) 120±15 108±18 85±22 81±22 89±22
Inotropes
Noradrenaline
(µg/min)
0 0 11.9±9.3
(n=5/7)
11.6±4.4
(n=8/8)
9.17±3.9
(n=13/14)
Dopamine
(µg/min)
0 0 220±92
(n=4/7)
163±103
(n=7/8)
136±49
(n=9/14)
Vasopressin
(unit/hr)
0 0 0 3.3±1.1
(n=5/8)
3.4±1.3
(n=4/14)
Fluid Balance
@ 24hr (ml)
378±251 1289±820 4346±1270 9226±2244* 9698±2514*
2
3
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